84 related articles for article (PubMed ID: 14580673)
1. Tissue-specific expression patterns of the RAGE receptor and its soluble forms--a result of regulated alternative splicing?
Schlueter C; Hauke S; Flohr AM; Rogalla P; Bullerdiek J
Biochim Biophys Acta; 2003 Oct; 1630(1):1-6. PubMed ID: 14580673
[TBL] [Abstract][Full Text] [Related]
2. RAGE and soluble RAGE: potential therapeutic targets for cardiovascular diseases.
Koyama H; Yamamoto H; Nishizawa Y
Mol Med; 2007; 13(11-12):625-35. PubMed ID: 17932553
[TBL] [Abstract][Full Text] [Related]
3. Mouse RAGE Variant 4 Is a Dominant Membrane Receptor that Does Not Shed to Generate Soluble RAGE.
Peng Y; Horwitz N; Lakatta EG; Lin L
PLoS One; 2016; 11(9):e0153657. PubMed ID: 27655067
[TBL] [Abstract][Full Text] [Related]
4. RAGE splicing variants in mammals.
Sterenczak KA; Nolte I; Murua Escobar H
Methods Mol Biol; 2013; 963():265-76. PubMed ID: 23296616
[TBL] [Abstract][Full Text] [Related]
5. Human intestine and placenta exhibit tissue-specific expression of RAGE isoforms.
Schwertner K; Gelles K; Leitner J; Steinberger P; Gundacker C; Vrticka R; Hoffmann-Sommergruber K; Ellinger I; Geiselhart S
Heliyon; 2023 Aug; 9(8):e18247. PubMed ID: 37533998
[TBL] [Abstract][Full Text] [Related]
6. The AGE-RAGE Axis and the Pathophysiology of Multimorbidity in COPD.
Reynaert NL; Vanfleteren LEGW; Perkins TN
J Clin Med; 2023 May; 12(10):. PubMed ID: 37240472
[TBL] [Abstract][Full Text] [Related]
7. The Hidden Role of Non-Canonical Amyloid β Isoforms in Alzheimer's Disease.
Busch L; Eggert S; Endres K; Bufe B
Cells; 2022 Oct; 11(21):. PubMed ID: 36359817
[TBL] [Abstract][Full Text] [Related]
8. Role and Therapeutic Potential of RAGE Signaling in Neurodegeneration.
Kinscherf NA; Pehar M
Curr Drug Targets; 2022; 23(12):1191-1209. PubMed ID: 35702767
[TBL] [Abstract][Full Text] [Related]
9. The Role of Advanced Glycation End Products and Its Soluble Receptor in Kidney Diseases.
Steenbeke M; Speeckaert R; Desmedt S; Glorieux G; Delanghe JR; Speeckaert MM
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408796
[TBL] [Abstract][Full Text] [Related]
10. Higher-Dose DHA Supplementation Modulates Immune Responses in Pregnancy and Is Associated with Decreased Preterm Birth.
Valentine CJ; Khan AQ; Brown AR; Sands SA; Defranco EA; Gajewski BJ; Carlson SE; Reber KM; Rogers LK
Nutrients; 2021 Nov; 13(12):. PubMed ID: 34959801
[TBL] [Abstract][Full Text] [Related]
11. AGEs and sRAGE Variations at Different Timepoints in Patients with Chronic Kidney Disease.
Molinari P; Caldiroli L; Dozio E; Rigolini R; Giubbilini P; Romanelli MMC; Messa P; Vettoretti S
Antioxidants (Basel); 2021 Dec; 10(12):. PubMed ID: 34943097
[TBL] [Abstract][Full Text] [Related]
12. Receptor for Advanced Glycation End Products (RAGE) and Its Polymorphic Variants as Predictive Diagnostic and Prognostic Markers of NSCLCs: a Perspective.
Mukherjee TK; Malik P; Hoidal JR
Curr Oncol Rep; 2021 Jan; 23(1):12. PubMed ID: 33399986
[TBL] [Abstract][Full Text] [Related]
13. Advanced Glycation End Products (AGE) and Soluble Forms of AGE Receptor: Emerging Role as Mortality Risk Factors in CKD.
Dozio E; Vettoretti S; Caldiroli L; Nerini-Molteni S; Tacchini L; Ambrogi F; Messa P; Corsi Romanelli MM
Biomedicines; 2020 Dec; 8(12):. PubMed ID: 33371369
[TBL] [Abstract][Full Text] [Related]
14. RAGE Signaling in Melanoma Tumors.
Olaoba OT; Kadasah S; Vetter SW; Leclerc E
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33256110
[TBL] [Abstract][Full Text] [Related]
15. Soluble Receptor for Advanced Glycation End Products and Its Forms in COVID-19 Patients with and without Diabetes Mellitus: A Pilot Study on Their Role as Disease Biomarkers.
Dozio E; Sitzia C; Pistelli L; Cardani R; Rigolini R; Ranucci M; Corsi Romanelli MM
J Clin Med; 2020 Nov; 9(11):. PubMed ID: 33238596
[TBL] [Abstract][Full Text] [Related]
16. The role of RAGE in host pathology and crosstalk between RAGE and TLR4 in innate immune signal transduction pathways.
Prantner D; Nallar S; Vogel SN
FASEB J; 2020 Dec; 34(12):15659-15674. PubMed ID: 33131091
[TBL] [Abstract][Full Text] [Related]
17. Inhibitors of Advanced Glycation End Product (AGE) Formation and Accumulation.
Sourris KC; Watson A; Jandeleit-Dahm K
Handb Exp Pharmacol; 2021; 264():395-423. PubMed ID: 32809100
[TBL] [Abstract][Full Text] [Related]
18. The impact of polytrauma on sRAGE levels: evidence and statistical analysis of temporal variations.
Negrin LL; Ristl R; Halat G; Heinz T; Hajdu S
World J Emerg Surg; 2019; 14():13. PubMed ID: 30923559
[TBL] [Abstract][Full Text] [Related]
19. Pathological Implications of Receptor for Advanced Glycation End-Product (
Serveaux-Dancer M; Jabaudon M; Creveaux I; Belville C; Blondonnet R; Gross C; Constantin JM; Blanchon L; Sapin V
Dis Markers; 2019; 2019():2067353. PubMed ID: 30863465
[TBL] [Abstract][Full Text] [Related]
20. Racial differences in circulating levels of the soluble receptor for advanced glycation endproducts in middle-aged and older adults.
Brinkley TE; Leng X; Nicklas BJ; Kritchevsky SB; Ding J; Kitzman DW; Hundley WG
Metabolism; 2017 May; 70():98-106. PubMed ID: 28403949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
